semaglutide for the treatment of obesity What's New in Treatment? GLP-1 Therapy for Obesity Requires

Net Quantity:80mg total per vial

Initially approved by the Food and Drug Administration to treat diabetes in 2017, semaglutide became the first FDA-approved drug for weight management in 2021

Meanwhile, our carb intake has risen since the agricultural revolution

Ref: Bulwer BE & Solomon SD #Cardiology #Echocardiography #EchoFirst #CardiacImaging #TeiIndex #HeartFailure #Cardiomyopathy #Ultrasound #POCUS #MedEd #MedicalEducation #CardioTwitter #CardiacFunction #LVFunction #RVFunction #Diastology #CriticalCare #InternalMedicine #Healthcare #MedicalImaging #HeartHealth #Cardiologist #CVImaging #UltrasoundEducation #MedTwitter To view or add a comment, sign in Explore related topics Explore content categories